Showing results (2291-2300 of 3,208) with videos related to

Sort By:
Pageof 321
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 17, 2019
Risk prediction models for survival after heart transplantation: A systematic reviewNatasha Aleksova, Ana C Alba, Victoria M Molinero, et al.
Plos Pathogens|June 20, 2019
Host-specialized fibrinogen-binding by a bacterial surface protein promotes biofilm formation and innate immune evasionAmy C Pickering, Pauline Vitry, Valeriia Prystopiuk, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 15, 2011
Escherichia coli heat-labile enterotoxin promotes protective Th17 responses against infection by driving innate IL-1 and IL-23 productionCorinna F Brereton, Caroline E Sutton, Pádraig J Ross, et al.
Clinical Hemorheology and Microcirculation|December 8, 2010
Image fusion with volume navigation of contrast enhanced ultrasound (CEUS) with computed tomography (CT) or magnetic resonance imaging (MRI) for post-interventional follow-up after transcatheter arterial chemoembolization (TACE) of hepatocellular carcinomas (HCC): Preliminary resultsC J Ross, J Rennert, D Schacherer, et al.
Clinical Endocrinology|September 10, 2004
Weight-related dosing, timing and monitoring hydrocortisone replacement therapy in patients with adrenal insufficiencyPeak M Mah, Richard C Jenkins, Amin Rostami-Hodjegan, et al.
Clinical Endocrinology|August 18, 2017
Absorption and tolerability of taste-masked hydrocortisone granules in neonates, infants and children under 6 years of age with adrenal insufficiencyUta Neumann, Martin J Whitaker, Susanna Wiegand, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|February 10, 2009
Epirubicin, cisplatin and protracted venous infusion 5-Fluorouracil chemotherapy for advanced salivary adenoid cystic carcinomaP J Ross, E M Teoh, R P A'hern, et al.
Cancer Chemotherapy and Pharmacology|December 24, 2008
A phase II trial evaluating capecitabine and irinotecan as second line treatment in patients with oesophago-gastric cancer who have progressed on, or within 3 months of platinum-based chemotherapyAlexandra Leary, L Assersohn, D Cunningham, et al.
Journal of Interferon Research|January 1, 1981
Properties of a human alpha-interferon purified from E. coli extractsR Wetzel, L J Perry, D A Estell, et al.
ESC Heart Failure|November 22, 2016
Barriers to goals of care discussions with hospitalized patients with advanced heart failure: feasibility and performance of a novel questionnaireNatasha Aleksova, Catherine Demers, Patricia H Strachan, et al.
Pageof 321